Q3 2025 Earnings Call Transcript November 13, 2025 Innate Pharma S.A. beats earnings expectations. Reported EPS is $-0.24551, ...
NF and mgk unite on WHO I WAS to explore generational trauma, anger, and breaking cycles. A raw breakdown of the ...
Alexion, AstraZeneca Rare Disease has received approval from the USFDA for Koselugo (selumetinib), an oral, selective MEK ...
The FDA today approved selumetinib (Koselugo; Alexion, AstraZeneca Rare Disease) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback